Tamoxifen and Raloxifene for Lowering Breast Cancer Risk

CPIC® Guideline for Tamoxifen based on CYP2D6 genotype · Most recent guideline publication: · Clinical Pharmacogenetics Implementation Consortium

Tamoxifen Application Tamoxifen is an antiestrogenic prodrug widely used to treat and prevent breast cancer Tamoxifen mediates its therapeutic effects through

tamoxifen Tamoxifen เป็นยาที่อยู่ในกลุ่ม Selective Estrogen Receptor Modulator จะใช้ในผู้ป่วยมะเร็งเต้านมที่มีตัวรับฮอร์โมน (Hormone Receptor

tamoxifen Tamoxifen prescribed for the prevention and treatment of breast cancer in men and women, and occasionally, to stimulate ovulation in women